Mesoblast
Farmaci cellulari e prodotti per terapia cellulare allogenica.
Mesoblast produce farmaci cellulari e prodotti per terapie cellulari allogeniche dalle sue attività a Melbourne. L'azienda fornisce sistemi sanitari, laboratori, partner OEM o clienti esportatori regolamentati nei suoi mercati primari quotati.
- Type
- Manufacturer
- Location
- Melbourne, Australia
- Founded
- 2004
- Website
- mesoblast.com
- Categories
- Forniture medicali e sanitarie
- Markets
- Australia, Stati Uniti, Germania, Giappone
Verified facts
- lei-lapsed (amber), checked 2026-08-07 GLEIF global LEI register (golden copy)
Claimed certifications
- Good Manufacturing Practice
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)